Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App NL ‐G‐F Mice
Authors:
- Ryan J. BevanRBRyan J. Bevan
- Emily MaguireEMEmily Maguire
- Eilish MackinnonEMEilish Mackinnon
- Elisa SalisESElisa Salis
- Thomas PhillipsTPThomas Phillips
- Elena SimonazziESElena Simonazzi
- Marieta VassilevaMVMarieta Vassileva
- Nicholas D. AllenNANicholas D. Allen
- Julie WilliamsJWJulie Williams
- Philip R. TaylorPTPhilip R. Taylor
Open Access
Abstract
The Alzheimer's disease protective P522R PLCG2 coding variant (rs72824905) is downstream of TREM2, but how it confers disease protection is poorly understood. Using a Plcg2 ‐R522 knock‐in mouse and Plcg2 ‐P522 control on both wildtype and Alzheimer's disease‐like App NL‐G‐F amyloidosis mouse backgrounds, aged mice were assayed for amyloid load, microglial activity, and synaptic integrity. In the absence of Alzheimer's disease‐like pathology, the R522 variant increased microglial coverage and was associated with reduced ramification complexity, fewer terminal points, and elevated lysosomal CD68 expression. On the App NL‐G‐F background, total amyloid burden was unaffected, but expression of the R522 variant led to increased plaque compaction compared to the P522 common variant. The protective R522 variant was also associated with: enhanced microglial engagement with less compact amyloid plaques; reduced microglial localisation around highly compacted plaques; protection from amyloid‐induced synapse loss; and decreased engulfment of synaptic material by microglia. Our data indicate a significant direct PLCγ2 role in controlling microglial‐plaque interactions and synaptic protection downstream of amyloid deposition, prioritizing it as a therapeutic target, potentially as an adjunct to other approaches, such as those targeting amyloid.Keywords
Funding Information
- UK Dementia Research Institute (DRI‐3203)
- Moondance Foundation
This publication has 41 references indexed in Scilit:
- Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain‐of‐function mutation in phospholipase Cγ2Journal of Thrombosis and Haemostasis, 2010
- β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementiaNeurology, 2010
- Phospholipase Cγ2 is necessary for separation of blood and lymphatic vasculature in miceDevelopment, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2Journal of Clinical Investigation, 2006
- Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque FormationThe Journal of Neuroscience, 2006
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006
- Variations in the human phospholipase Cγ2 gene in patients with B-cell defects of unknown etiologyImmunogenetics, 2001
- Regulation of the phospholipase C‐γ2 pathway in B cellsImmunological Reviews, 2000
- Multicolor “DiOlistic” Labeling of the Nervous System Using Lipophilic Dye CombinationsNeuron, 2000